Table 3.
Patients with in situ vulvar disease |
||||
---|---|---|---|---|
Dysfunction | Healthy counterparts† |
Before treatment |
1 year post- treatment |
Follow-up |
Inhibited desire |
21% | 13% | 23% | 15% |
Inhibited excitement |
12% | 15% | 31% | 36% |
Inhibited orgasm |
10% | 18% | 36% | 28% |
Dyspareunia | 0% | 5% | 10% | 8% |
Adapted from Andersen et al.(2)
The sample of healthy counterparts were all sexually active at assessment.